Literature DB >> 18378884

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

M W Vernooij1, A van der Lugt, M A Ikram, P A Wielopolski, W J Niessen, A Hofman, G P Krestin, M M B Breteler.   

Abstract

BACKGROUND: Cerebral microbleeds are focal deposits of hemosiderin that can be visualized with MRI. Little is known on their prevalence in the general population and on their etiology. It has been suggested that, in analogy to spontaneous intracranial hemorrhage, the etiology of microbleeds differs according to their location in the brain, with lobar microbleeds being caused by cerebral amyloid angiopathy and deep or infratentorial microbleeds resulting from hypertension and atherosclerosis. We investigated the prevalence of and risk factors for microbleeds in the general population aged 60 years and older.
METHODS: This study is based on 1,062 persons (mean age 69.6 years) from the population-based Rotterdam Scan Study. MRI was performed at 1.5 T and included a sequence optimized to increase the conspicuity of microbleeds. We assessed the relation of APOE genotype, cardiovascular risk factors, and markers of small vessel disease to the presence and location of microbleeds with multiple logistic regression.
RESULTS: Overall prevalence of cerebral microbleeds was high and increased with age from 17.8% in persons aged 60-69 years to 38.3% in those over 80 years. APOE epsilon 4 carriers had significantly more often strictly lobar microbleeds than noncarriers. In contrast, cardiovascular risk factors and presence of lacunar infarcts and white matter lesions were associated with microbleeds in a deep or infratentorial location but not in a lobar location.
CONCLUSION: The prevalence of cerebral microbleeds is high. Our data support the hypothesis that strictly lobar microbleeds are related to cerebral amyloid angiopathy, whereas microbleeds in a deep or infratentorial location result from hypertensive or atherosclerotic microangiopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378884     DOI: 10.1212/01.wnl.0000307750.41970.d9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  253 in total

1.  Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping.

Authors:  Tian Liu; Krishna Surapaneni; Min Lou; Liuquan Cheng; Pascal Spincemaille; Yi Wang
Journal:  Radiology       Date:  2011-11-04       Impact factor: 11.105

Review 2.  [Zerebrale Amyloidangiopathie : Cerebral amyloid angiopathy].

Authors:  F Block
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 3.  The challenge of mixed cerebrovascular disease.

Authors:  Mark Fisher
Journal:  Ann N Y Acad Sci       Date:  2010-10       Impact factor: 5.691

Review 4.  Genetics of stroke.

Authors:  Jin-min Guo; Ai-jun Liu; Ding-feng Su
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

5.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 6.  Imaging of Cerebral Microbleeds.

Authors:  J Linn
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

7.  Cerebral Microbleeds, CSF p-Tau, and Cognitive Decline: Significance of Anatomic Distribution.

Authors:  G C Chiang; J C Cruz Hernandez; K Kantarci; C R Jack; M W Weiner
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

8.  Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study.

Authors:  Nan Wang; Gilles Allali; Chandrasekharan Kesavadas; Mohan L Noone; Vayyattu G Pradeep; Helena M Blumen; Joe Verghese
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 9.  [Cerebral amyloid angiopathy and dementia].

Authors:  P Berlit; K Keyvani; M Krämer; R Weber
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

Review 10.  The impact of cerebrovascular aging on vascular cognitive impairment and dementia.

Authors:  Tuo Yang; Yang Sun; Zhengyu Lu; Rehana K Leak; Feng Zhang
Journal:  Ageing Res Rev       Date:  2016-09-28       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.